3ANS image
Deposition Date 2010-09-08
Release Date 2011-01-19
Last Version Date 2023-11-01
Entry Detail
PDB ID:
3ANS
Title:
Human soluble epoxide hydrolase in complex with a synthetic inhibitor
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.98 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.22
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Epoxide hydrolase 2
Gene (Uniprot):EPHX2
Chain IDs:A, B
Chain Length:336
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors
J.Med.Chem. 54 851 857 (2011)
PMID: 21192659 DOI: 10.1021/jm101273e

Abstact

Ligand efficiency is frequently used to evaluate fragment compounds in fragment-based drug discovery. We applied ligand efficiency indices in a conventional virtual screening-initiated lead generation study of soluble epoxide hydrolase inhibitors. From a considerable number of screening hits, we carefully selected a compound exhibiting relatively weak inhibitory activity but high ligand efficiency. This ligand efficiency-guided selection could reveal compounds possessing preferable lead-like characteristics in terms of molecular size and lipophilicity. The following hit-to-lead medicinal chemistry campaign successfully led to a more potent, ADMET-clean, lead-like compound preserving high ligand efficiency. Retrospective analyses, including consideration of the more recently proposed indices of ligand efficiency, shed light on the validity of our hit triage and hit-to-lead studies. The present work proposes a practical methodology for lead generation using the concept of ligand efficiency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures